Senior Director, Health Economics and Outcomes Research / Real World Evidence

IDEAYA Biosciences•South San Francisco, CA

23h•$282,000 - $349,000•Hybrid

About The Position

IDEAYA is a precision medicine oncology company committed to the discovery, development, and commercialization of transformative therapies for cancer. Our approach integrates expertise in small-molecule drug discovery, structural biology and bioinformatics with robust internal capabilities in identifying and validating translational biomarkers to develop tailored, potentially first-in-class targeted therapies aligned to the genetic drivers of disease. We have built a deep pipeline of product candidates focused on synthetic lethality and antibody-drug conjugates, or ADCs, for molecularly defined solid tumor indications. Our mission is to bring forth the next wave of precision oncology therapies that are more selective, more effective, and deeply personalized with the goal of altering the course of disease and improving clinical outcomes for patients with cancer. When you're at IDEAYA, you will be in the midst of brilliant minds working on precision medicine therapies to help cancer patients. We are passionate and committed about being on the forefront of oncology medicine, which means we all have a high internal drive that is at the very core of every person at IDEAYA. We are inquisitive, ask deep questions, and are data-driven innovators who like to collaborate and use teamwork to move science forward. We are seeking a Senior Director of Health Economics and Outcomes Research / Real World Evidence (HEOR/RWE) to join the IDEAYA Commercial team. The Senior Director, HEOR/RWE will be responsible for shaping and executing IDEAYA’s health economics, outcomes research, and real-world evidence strategy for the launch of darovasertib in metastatic uveal melanoma (mUM). This leader will play a pivotal role in generating evidence in a very high unmet disease area for payers, providers, and patients. They will have an opportunity to take innovative approaches to value demonstration in orphan diseases, biomarker-driven populations, and unique combination treatments. While the initial focus will be on darovasertib, this role will evolve over time to include direct reports and contribute on the global launches of IDEAYA’s exciting pipeline of oncology assets. This position is based in our South San Francisco headquarter offices and required to be onsite four days per week per our company policy.

Requirements

Advanced, doctoral level degree in related discipline with at least 10-15 years of related experience
Experience in Biotech/Pharmaceutical industry in US HEOR/RWE and with market access strategies
Experience with rare disease and oral drugs is strongly preferred
Demonstrated success with US commercialization and launches
Deep technical knowledge and experience with Clinical and HEOR / RWE data sets, methodologies, analyses, and processes to optimize execution of value evidence tactics
Experience developing US and global value evidence generation plans for pipeline assets
Experience establishing relationships with clinical and HEOR experts
Experience interacting with US access decision-makers
Excellent communication and presentation skills, ability to present to diverse stakeholders including external partners, healthcare professionals and senior leaders
Excellent organizational, project management and problem-solving skills
Ability to thrive in a fast-evolving environment
In-office role (4x per week) with 15% estimated travel to vendor partners and relevant conferences/meetings as deemed necessary
This position requires you to be fully vaccinated from COVID-19, subject to reasonable accommodations for medical or religious reasons, and/or as otherwise required by applicable law.

Nice To Haves

Experience with rare disease and oral drugs is strongly preferred

Responsibilities

Develop and execute the HEOR and RWE strategy to support US value demonstration for darovasertib at launch and through its lifecycle
Collaborate with Market Access, Medical Affairs and Clinical Development to evaluate data gaps and develop robust evidence generation and publication plans
Develop and execute core evidence-generation activities including chart reviews, literature reviews, PRO studies, and micro-costing analyses to strengthen the clinical and economic differentiation of the product
Design and implement real-world data analyses to articulate the current patient demographics, treatment patterns, and outcomes for mUM patients
Develop comprehensive health economic model analyses to demonstrate value, inform pricing strategy, and support reimbursement decisions
Partner with Market Access to develop robust and compelling clinical, humanistic, and economic value propositions and oversee development of AMCP and Global Value Dossiers
Lead the external dissemination of HEOR/RWE deliverables including publications, presentations, and professional conferences
Develop, train, and implement the resources that support field HEOR efforts with key customers; ensure programs and materials comply with SOPs and Medical, Legal & Regulatory (MLR) reviews
Engage and collaborate with external partners including payers, providers, and other access decision-makers to establish / maintain strong partnerships and gather insights
Support field team engagements during Preapproval Information Exchange (PIE) and post-approval interactions to educate payers and provider access stakeholders on darovasertib
Stay current with advancements in methodologies and best practices; Closely monitor new trends in health policy and payer environment and integrate into cross-functional strategies
Influence the design of IDEAYA’s clinical development programs through global price and market access and commercial opportunity assessments
Oversee budgeting and financial planning for all HEOR/RWE activities